摘要
目的:探讨血循环中不同分子量多聚体形式的脂联素(APN)在高胆固醇血症患者中的分布及其与冠心病的相关性。方法:研究对象包括148例男性高胆固醇血症患者,按是否并发冠心病又分为单纯高胆固醇组(n=68)和并发冠心病组(n=80),另选年龄及体质量指数(BMI)与高胆固醇组相匹配的健康查体者(健康对照组,n=84)。排除糖尿病、高血压病、肾脏疾病及重度吸烟人群。结果:与健康对照组相比,高分子量APN和中分子量APN在单纯高胆固醇组显著增加[高分子量APN亚组:(4.98±0.87)mg/L vs.(2.51±0.33)mg/L,P<0.01;中分子量APN亚组:(2.20±0.36)mg/L vs.(1.01±0.15)mg/L,P<0.01],而在并发冠心病组患者中显著降低,且与健康对照组无显著差异。与其它APN多聚体相比,高分子量APN与冠心病相关心血管危险因素———总胆固醇(TC,r=0.345,P<0.05)、高密度脂蛋白胆固醇(HDL-C,r=0.325,P<0.05)及尿酸(UA,r=-0.472,P<0.01)水平密切相关。Logistic回归分析显示高分子量APN是高胆固醇血症患者发生冠心病的独立危险因素(OR,8.43;P<0.05)。结论:高胆固醇血症患者中高分子量APN水平的降低与并发冠心病有相关性。
AIM : To determine the circulatory distribution of hormone adiponectin (APN) multimers and their relationships with cardiovascular disease (CVD)-related biochemical indicators in patients with hypereholesterolemia (HC). METHODS: A total of 148 age- and body mass index (BMI)-matched male patients with HC (80 with CVD and 68 without CVD) and 84 healthy male controls were enrolled. Diabetes mellitus, hypertension, nephropathy and smoking habit constituted exclusion criteria. RESULTS: Both high molecular weight (HMW) and medium molecular weight (MMW) forms of APN significantly increased in HC without CVD (HMW: 4.98±0.87 vs. 2.51 ±0.33 in controls, P 〈0.01; MMW: 2. 20 ±0. 36 vs. 1.01 ±0. 15 in control, P 〈0. 01 ) and were comparable to those in patients with HC- related CVD (HCVD). In comparison to other APN oligomers, HMW was most closely associated with the HCVD-related biochemical factors : total cholesterol ( r = 0. 345, P 〈 0. 05 ) , high-density lipoprotein cholesterol (HDLc, r = 0. 325, P 〈 0. 05) and uric acid ( UA, r = - 0. 472, P 〈 0. 01 ). Additional analysis via binary logistic regression suggested HMW APN was an independent predictor of risk for HCVD (OR, 8.434; P =0. 018). CONCLUSION: Reduced HMW isoform concentrations may predict the possibility of cardiovascular complications in HC patients.
出处
《心脏杂志》
CAS
2012年第4期446-449,共4页
Chinese Heart Journal
基金
教育部留学回国人员科研启动基金资助(HG2401)
关键词
脂联素
高胆固醇血症
冠状动脉疾病
危险因素
adiponectin muhimers
high molecular weight adiponectin
hypercholesterolemia
cardiovas- cular disease
cardiovascular risk factors